MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making

Menopause Clinical Trial

Official title:

MsFLASH: Living a Healthy Menopause, Aim 2 Randomized Controlled Trial of MyMenoPlan

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05299983
• Other study ID #: 140604
• Status: Active, not recruiting
• Phase: N/A
• Start date: January 15, 2022
• Est. completion date: March 31, 2022

Study information

• Verified date: March 2022
• Source: University of California, San Diego
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

As part of a National Institute on Aging -funded R01, the investigators developed an evidence-based, multi-media digital resource entitled MyMenoPlan to help women learn about the menopause transition, and the symptoms and treatments of perimenopause/menopause. MyMenoPlan is also designed to help women learn about the effectiveness of treatments for a comprehensive list of midlife symptoms and compare treatments that may help with the specific symptoms women are experiencing.

Description:

The purpose of this research study is to: 1. Investigate how women randomly assigned to visit MyMenoPlan use the website (time spent on website, treatment and symptom page views, use of interactive tools, and use of the MyMenoPlan tool). 2. Compare the ratings of women randomly assigned to MyMenoPlan to those randomly assigned to other menopause websites for perceived quality of information, readability, self-efficacy, and credibility of these online menopause resources.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 410
• Est. completion date: March 31, 2022
• Est. primary completion date: March 31, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 40 Years to 60 Years

Eligibility

Inclusion Criteria:

• As stated above

Exclusion Criteria:

• N/A

Related Conditions & MeSH terms

• Menopause
• Postmenopause
• Premenopause

Intervention

Other:
• MyMenoPlan
Participants are asked to spend at least 20 minutes on the website (MyMenoPlan) assigned to them.
• Control
Participants are asked to spend at least 20 minutes on at least one of the following websites: North American Menopause Society: https://www.menopause.org/for-women National Institute on Aging: https://www.nia.nih.gov/health/topics/menopause The Office on Women's Health-Menopause: https://www.womenshealth.gov/menopause

Locations

Country	Name	City	State
United States	UC San Diego	La Jolla	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, San Diego

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Perceived Quality of Information	This 7-item, 5-point Likert scale (1- Strongly disagree to 5 - Strongly agree) is adapted from the Post-Study System Usability Questionnaire (PSSUQ) in Lewis (1995).; Items: Reading the information made me feel in more control of my perimenopause/menopause.; The information on the website(s) was helpful to me.; I found the information I was looking for.; The information answered my questions about perimenopause/menopause.; I liked the website (s).; I would have liked more in-depth information. (reverse-coded); The website(s) were fairly comprehensive about perimenopause /menopause.	Each survey question is answered after spending at least 20 minutes on the assigned website(s)
Primary	Readability	This 2-item, 5-point Likert (1- Strongly disagree to 5 - Strongly agree)scale was derived from the Standardized User Experience Percentile Rank Questionnaire (SUPR-Q) in Sauro (1995).; Items: The information I read was clear.; The information I read was easy for me to understand.	Each survey question is answered after spending at least 20 minutes on the assigned website(s)
Primary	Self-Efficacy for Managing Menopause Symptoms	This is a newly developed Likert scale (1- Strongly disagree to 5 - Strongly agree) for assessing participants' beliefs in their own abilities in managing menopausal symptoms.; Items: If I want to, I am certain I could figure out the treatments or coping strategies that would work best for me.; I feel I could treat or cope with my symptoms of perimenopause/menopause if I want to.	Each survey question is answered after spending at least 20 minutes on the assigned website(s)
Primary	Credibility	This 2-item, 5-point Likert (1- Strongly disagree to 5 - Strongly agree) scale was derived from the Standardized User Experience Percentile Rank Questionnaire (SUPR-Q) in Sauro (1995).; Items: The information is credible.; The information is trustworthy.	Each survey question is answered after spending at least 20 minutes on the assigned website(s)